Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma. - Wikidata - awgldk - TriplyDB

Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

http://www.wikidata.org/entity/Q33570215

about

Adrenocortical zonation, renewal, and remodeling The challenge of developmental therapeutics for adrenocortical carcinoma Dysregulation of ubiquitin ligases in cancer Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors.A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis.Genetic screening reveals a link between Wnt signaling and antitubulin drugs.Mouse models of adrenocortical tumors.Downregulation of CDC27 inhibits the proliferation of colorectal cancer cells via the accumulation of p21Cip1/Waf1.Quantitative analysis of gene expression in fixed colorectal carcinoma samples as a method for biomarker validation.ATR-101 disrupts mitochondrial functions in adrenocortical carcinoma cells and in vivo.RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.5th International ACC Symposium: Classification of Adrenocortical Cancers from Pathology to Integrated Genomics: Real Advances or Lost in Translation?P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.Genetics of Adrenocortical Development and Tumors.Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach.CDC27 Induces Metastasis and Invasion in Colorectal Cancer via the Promotion of Epithelial-To-Mesenchymal Transition.Activating FGFR1 Mutations in Sporadic Pheochromocytomas.Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis.The curious case of Gαs gain-of-function in neoplasia.Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survival.SLC12A7 alters adrenocortical carcinoma cell adhesion properties to promote an aggressive invasive behavior.Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era The human adrenal cortex: growth control and disorders

P2860

Q26852504-6B984DAF-F441-4238-8DAA-7F057A005E1D Q28072970-976F9B02-A920-4248-88EC-82A1E282B372 Q28086796-FF87406E-64E3-4F8A-B36C-F03ADBC56B0A Q28553895-31BF1027-BB02-42B1-888E-B947BDD91586 Q34677263-8D05B9AC-C8CD-49C3-BED8-EA423A2FB07D Q36210460-00225777-CBE8-43B0-8830-019C84F0F4FA Q36294469-CB574197-6AFD-46DB-92A2-1ED1DC7A1DEA Q36441268-03BAC74F-4968-445C-B27B-C9F186CA7CD5 Q36482758-C0443920-7120-4766-B7B8-B37C25B1F62C Q36751768-12B48C05-123B-44D3-9CD9-8EDD1E016BE0 Q36931183-D60578D5-16F9-4474-AA04-805F9620FC6B Q36951577-B43D2413-14AC-4E6E-A679-8950724EF304 Q37688580-15956BF0-007E-4B09-BC5C-0EC18D3BD69E Q38671542-34A086DB-F6FB-405C-B30B-6DC709BCB14A Q38860968-20C335CB-0F05-4A7F-985D-17AC6BB8F0BB Q39035325-B8F2B666-D85D-4876-9EC4-04A1AABE4736 Q39286333-AF09FD31-2BC1-474E-8D8E-3F8ED1E0363F Q40198016-3CD2AED3-C3E2-4977-95A2-6183E3D777EC Q41242267-CC133132-964E-4594-AF16-04AD385DCC67 Q47959074-52569E75-018A-4F66-BEB2-4F8412BE59DA Q48108818-BDA132A1-4BB7-4DDE-AAB9-52727969A6AA Q54955004-8589FC1F-1ED5-49A5-95FC-3A5D47CAF2AC Q55291718-D8A369EF-ECAE-46AB-A2C5-F01D795D29F4 Q55322208-EA1AD3F2-A9C4-4BFB-88CA-5B78C121D42D Q58550571-8413962E-02DD-4C95-8920-DDCEF624EC84 Q58699198-CFA69D2C-EBAE-40C5-918B-54AD056D5C15

P2860

Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

http://www.wikidata.org/entity/Q33570215

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Whole-exome sequencing charact ...... s in adrenocortical carcinoma.

@ast

Whole-exome sequencing charact ...... s in adrenocortical carcinoma.

@en

Whole-exome sequencing charact ...... s in adrenocortical carcinoma.

@nl

type

label

Whole-exome sequencing charact ...... s in adrenocortical carcinoma.

@ast

Whole-exome sequencing charact ...... s in adrenocortical carcinoma.

@en

Whole-exome sequencing charact ...... s in adrenocortical carcinoma.

@nl

prefLabel

Whole-exome sequencing charact ...... s in adrenocortical carcinoma.

@ast

Whole-exome sequencing charact ...... s in adrenocortical carcinoma.

@en

Whole-exome sequencing charact ...... s in adrenocortical carcinoma.

@nl

P1433

Q33570215-D94CCCF6-7DF5-41A5-A613-6FA000E4E412

P1476

Q33570215-6F8EF8CA-0E20-4EB8-8F7A-93DB9280A426

P2093

Q33570215-034069FB-5B40-4F4E-8819-A020582A01A6

Q33570215-287D5425-1095-4950-AF97-17C4E265C9CA

Q33570215-2E3AA3D9-8AE0-4478-BCD3-5FAEACF89655

Q33570215-46FE976E-0554-4B07-8FA3-FD6B40D3B8F9

Q33570215-4ED00AEC-3217-4C94-AAEE-6B935BFE01D7

Q33570215-5265DDF8-D8A7-4E3B-8D3A-0BD042A976BF

Q33570215-66436C50-6ED1-445F-AF29-4AD26AFDA737

Q33570215-7DC2BBAB-DAF4-4382-860A-A2231C857947

Q33570215-8A8625ED-ACA3-4421-8347-8FD848536B72

Q33570215-93E264D5-500A-48EC-91DD-1C8CDC5136BB

P2860

Q33570215-05B41503-BBC0-493D-A229-C225BC1E0416

Q33570215-12016FA0-BA92-4945-B23B-F4CC1D743B03

Q33570215-12D7BF8E-1847-4242-ACAE-CD6708784F49

Q33570215-138AC16C-D00A-4152-990A-6D00E3B0C855

Q33570215-1F616A3D-277C-41B4-9D11-19D36D4DAF3A

Q33570215-26BC63A8-47AC-4EDA-8872-6CAF5C51CD9D

Q33570215-2CC5B72D-8871-4DCB-AA80-CA265534DEB7

Q33570215-34B4C73F-1E1E-4C59-91D7-A937A05C0A28

Q33570215-389E0960-EDF8-4215-AB90-80C898F6029C

Q33570215-3E1E035B-6CC8-4AC0-921E-1F88876FC06D

P304

Q33570215-98604474-2A0C-4AC0-BA3D-F8BD0E83DB52

P31

Q33570215-48B6FC7D-F97D-4E0F-B2C1-921D7FCC71FF

P356

Q33570215-3F0202A3-F7EC-4B6F-877A-87C9C0E052C3

P407

Q33570215-574190B9-FCB8-495C-9D73-31CA0AD11EAF

P433

Q33570215-A393697D-058A-4217-AB4C-865F16EF741D

P478

Q33570215-4EBAF39A-DB9F-479E-AC06-FC177DE3AF06

P50

Q33570215-02298903-E4F7-4E56-8733-A49B51CA8390

Q33570215-0345E349-AD95-4403-8091-98243F3FB662

Q33570215-12FD9F11-9E84-4B1E-ABC9-0CF548BB40CB

Q33570215-4A7E83DD-4260-45A3-A83E-5A5E03B2D59F

Q33570215-DFE16232-C370-44CE-A51D-A1FA5AEE66C1

P577

Q33570215-22DDD894-0867-4531-9B34-BD2E03C8D2B6

P698

Q33570215-9110969C-4456-4F9D-94D1-D56812C49ABB

P932

Q33570215-A127CAAC-2D70-4E49-A162-7487AFAEF1C5

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Whole-exome sequencing charact ...... ns in adrenocortical carcinoma

@en

P2093

Anders Höög

http://www.w3.org/2001/XMLSchema#string

Anna-Carinna Suttorp

http://www.w3.org/2001/XMLSchema#string

Annabelle L Fonseca

http://www.w3.org/2001/XMLSchema#string

Carol Nelson-Williams

http://www.w3.org/2001/XMLSchema#string

Catharina Larsson

http://www.w3.org/2001/XMLSchema#string

David L Rimm

http://www.w3.org/2001/XMLSchema#string

John D Overton

http://www.w3.org/2001/XMLSchema#string

Joseph Schlessinger

http://www.w3.org/2001/XMLSchema#string

Manju L Prasad

http://www.w3.org/2001/XMLSchema#string

Martin Bäckdahl

http://www.w3.org/2001/XMLSchema#string

P2860

Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors

ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Highly recurrent TERT promoter mutations in human melanoma

Caught up in a Wnt storm: Wnt signaling in cancer

Human cancers express mutator phenotypes: origin, consequences and targeting.

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors

Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors

Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism

P304

E493-502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2014-3282

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

John W Kunstman

P577

2014-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25490274

http://www.w3.org/2001/XMLSchema#string

P932

5393505

http://www.w3.org/2001/XMLSchema#string